Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
Biological Psychiatry Global Open Science · 2023-04 · 3 (2) · 187-196
DOI: 10.1016/j.bpsgos.2022.02.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biological Psychiatry Global Open Science, 2023-04. Verfasst von Jin-Gang He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
Pharmacological and anatomical evidence suggests that abnormal glutamatergic neurotransmission may be associated with the pathophysiology of depression. Compounds that act as NMDA receptor antagonists may be a potential treatment for depression, notably the rapid-acting agent ketamine. The rapid-acting and sustained antidepressant effects of ketamine rely on the activation of AMPA receptors (AMPARs). As the key elements of fast excitatory neurotransmission in the brain, AMPARs are crucially involved in synaptic plasticity and memory. Recent efforts have been directed toward investigating the bidirectional dysregulation of AMPAR-mediated synaptic transmission in depression. Here, we summarize the published evidence relevant to the dysfunction of AMPAR in stress conditions and review the recent progress toward the understanding of the involvement of AMPAR trafficking in the pathophysiology of depression, focusing on the roles of AMPAR auxiliary subunits, key AMPAR-interacting proteins, and posttranslational regulation of AMPARs. We also discuss new prospects for the development of improved therapeutics for depression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Research Center for Depression, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
He, J. G., Zhou, H. Y., Wang, F., & Chen, J. G. (2023). Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking. Biological Psychiatry Global Open Science, 3(2), 187-196. https://doi.org/10.1016/j.bpsgos.2022.02.007
Vancouver
He JG, Zhou HY, Wang F, Chen JG. Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking. Biological Psychiatry Global Open Science. 2023;3(2):187-196. doi:10.1016/j.bpsgos.2022.02.007
BibTeX
@article{He2023,
author = {He, Jin-Gang and Zhou, Hai-Yun and Wang, Fang and Chen, Jian-Guo},
title = {Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking},
journal = {Biological Psychiatry Global Open Science},
year = {2023},
volume = {3},
number = {2},
pages = {187--196},
doi = {10.1016/j.bpsgos.2022.02.007}
}
EUVIMED